Pharmacotherapy of schizophrenia: toward a metabolomic-based approach

Tayeb, HO; Murad, HA; Rafeeq, MM; Tarazi, FI

Murad, HA (reprint author), King Abdulaziz Univ, Fac Med, Dept Pharmacol, Jeddah, Saudi Arabia.

CNS SPECTRUMS, 2019; 24 (3): 281

Abstract

Approximately 20%-30% of schizophrenia patients are resistant to current standard pharmacotherapies. Recent schizophrenia research aims to identify sp......

Full Text Link